EglN3 hydroxylase stabilizes BIM-EL linking VHL type 2C mutations to pheochromocytoma pathogenesis and chemotherapy resistance. (Record no. 29969511)
[ view plain ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 02218 a2200625 4500 |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20250518053028.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
| fixed length control field | 202003s 0 0 eng d |
| 022 ## - INTERNATIONAL STANDARD SERIAL NUMBER | |
| International Standard Serial Number | 1091-6490 |
| 024 7# - OTHER STANDARD IDENTIFIER | |
| Standard number or code | 10.1073/pnas.1900748116 |
| Source of number or code | doi |
| 040 ## - CATALOGING SOURCE | |
| Original cataloging agency | NLM |
| Language of cataloging | eng |
| Transcribing agency | NLM |
| 100 1# - MAIN ENTRY--PERSONAL NAME | |
| Personal name | Li, Shuijie |
| 264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
| Date of production, publication, distribution, manufacture, or copyright notice | 20200323 |
| 245 00 - TITLE STATEMENT | |
| Title | EglN3 hydroxylase stabilizes BIM-EL linking VHL type 2C mutations to pheochromocytoma pathogenesis and chemotherapy resistance. |
| Medium | [electronic resource] |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
| Name of publisher, distributor, etc. | Proceedings of the National Academy of Sciences of the United States of America |
| Date of publication, distribution, etc. | 08 2019 |
| 300 ## - PHYSICAL DESCRIPTION | |
| Extent | 16997-17006 p. |
| Other physical details | digital |
| 500 ## - GENERAL NOTE | |
| General note | Publication Type: Journal Article |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Adrenal Gland Neoplasms |
| General subdivision | drug therapy |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Animals |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Apoptosis |
| General subdivision | drug effects |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Bcl-2-Like Protein 11 |
| General subdivision | genetics |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Cell Hypoxia |
| General subdivision | drug effects |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Cisplatin |
| General subdivision | pharmacology |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Drug Resistance, Neoplasm |
| General subdivision | drug effects |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Humans |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Hydroxylation |
| General subdivision | drug effects |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Hypoxia-Inducible Factor-Proline Dioxygenases |
| General subdivision | genetics |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | MAP Kinase Signaling System |
| General subdivision | drug effects |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Mice |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Mice, Knockout |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Mutation |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | PC12 Cells |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Pheochromocytoma |
| General subdivision | drug therapy |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Proteolysis |
| General subdivision | drug effects |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Rats |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Von Hippel-Lindau Tumor Suppressor Protein |
| General subdivision | genetics |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Rodriguez, Javier |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Li, Wenyu |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Bullova, Petra |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Fell, Stuart M |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Surova, Olga |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Westerlund, Isabelle |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Topcic, Danijal |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Bergsland, Maria |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Stenman, Adam |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Muhr, Jonas |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Nistér, Monica |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Holmberg, Johan |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Juhlin, C Christofer |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Larsson, Catharina |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | von Kriegsheim, Alex |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Kaelin, William G |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Schlisio, Susanne |
| 773 0# - HOST ITEM ENTRY | |
| Title | Proceedings of the National Academy of Sciences of the United States of America |
| Related parts | vol. 116 |
| -- | no. 34 |
| -- | p. 16997-17006 |
| 856 40 - ELECTRONIC LOCATION AND ACCESS | |
| Uniform Resource Identifier | <a href="https://doi.org/10.1073/pnas.1900748116">https://doi.org/10.1073/pnas.1900748116</a> |
| Public note | Available from publisher's website |
No items available.